TGA Approval

ULTOMIRIS ravulizumab rch 10 mg/mL concentrated solution for intravenous infusion vial (311926)

ARTG ID

311926

ARTG Name

ULTOMIRIS ravulizumab rch 10 mg/mL concentrated solution for intravenous infusion vial

Sponsor

Alexion Pharmaceuticals Australasia Pty Ltd

ARTG Date

October 17, 2019

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

ALEXION PHARMACEUTICALS AUSTRALASIA PTY LTD

Ingredient Name

ravulizumab

Empowering clinical research with data-driven insights and AI-powered tools.

ULTOMIRIS ravulizumab rch 10 mg/mL concentrated solution for intravenous infusion vial (311926) - TGA 批准文号 | MedPath